Alyeska Investment Group
ENZY

Alyeska Investment Group’s Enzymotec Ltd ENZY Stock Holding History

Alyeska Investment Group’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-51,840
Closed -$703K – 503
2014
Q2 		$703K Sell
51,840
-133,693
-72% -$2.24M 0.02% 370
2014
Q1 		$4.08M Buy
+185,533
New +$4.92M 0.11% 216
2013
Q4 		– Sell
-50,000
Closed -$828K – 413
2013
Q3 		$828K Buy
+50,000
New +$868K 0.03% 269

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MACM
March Altus Capital Management Greenwich, Connecticut $16M AUM 18.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Alyeska Investment Group's ENZY Position: Q3 2014 in Review

Alyeska Investment Group sold out of Enzymotec Ltd (ENZY) in Q3 2014, closing a stake of 51,840 shares — an estimated $703K sold.

Alyeska Investment Group first reported a position in ENZY in Q3 2013 and held it in 3 quarters. The position peaked at $4.08M in Q1 2014. 22 funds tracked by Wall St. Rank hold ENZY as of Q3 2014.

  • Alyeska Investment Group reported no remaining Enzymotec Ltd position as of Q3 2014 after selling out during the quarter.
  • Alyeska Investment Group sold 51,840 Enzymotec Ltd shares in Q3 2014, an estimated $703K.
  • Alyeska Investment Group first reported a position in Enzymotec Ltd in Q3 2013 and held it in 3 quarters.
  • Alyeska Investment Group's Enzymotec Ltd position peaked at $4.08M in Q1 2014.
  • 22 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q3 2014.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.